Skip to main content
Clinical Trials/IRCT20200406046966N1
IRCT20200406046966N1
Completed
Phase 3

Evaluation of patient's sedation and surgeon's satisfaction by applying the combination of Dexmedetomidine and Lidocaine during wisdom tooth surgery

Esfahan University of Medical Sciences0 sites26 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
26
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • According to the ASA physical status classification system, patient should be ASA I or ASA II (normal healthy patient or patient with mild systemic disease).
  • Patient with informed consent.
  • Patient's age should be between 18\-30 years.
  • Patients should have two wisdom teeth (classified in the same class by Pell \& Gregory; mesioangular impaction, level B, class 1 or 2\), which are similar in terms of surgical severity;
  • No general contraindications (in these patients use of dexmedetomidine is contraindicated: patients with low blood pressure, bradycardia, sinus disorder, unstable high blood pressure, arousability, tachyphylaxis and liver disorders.)
  • No lesions and malignancies at the surgical site;
  • No smoking.

Exclusion Criteria

  • Patient with wisdom tooth surgery on one side;
  • Occurring medical problems during surgery;
  • Patient who needs more than one cartridge injection;
  • Surgery lasting more than 20 minutes.

Outcomes

Primary Outcomes

Not specified

Similar Trials